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ABSTRACT
Background: Pemphigus is a worldwide disease and varies in its clinical profi le and epidemiology in diff erent 
regions of the world. The disease is rare and few epidemiological data are available. ObjecƟ ve: The purpose 
of this study was to evaluate the epidemiologic, clinical, and therapeuƟ c features of pemphigus in Lumbini 
Medical College.  Methods: We retrospecƟ vely invesƟ gated a total of 70 paƟ ents with pemphigus. The 
parameters including age at diagnosis, sex, diagnosƟ c methods and treatment outcome of the disease. Results: 
The mean age at the onset was 41.3 years. The male-to-female raƟ o was 1.18:1. Most of the paƟ ents were 
cured at the end of the treatment. Rest were clinically improved. Conclusion: Pemphigus vulgaris (PV) is the 
most common clinical subtype in our centre. The disease  is more frequent in the fi Ō h decade of life and has 
a male predominance in our region. 
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INTRODUCTION
The term pemphigus refers to a group of autoimmune 
blistering diseases of the skin and mucous membranes 
characterized histologically by intraepidermal blister 
and acantholyƟ c cells and immunopathologically by the 
fi nding of IgG, IgA and C3 deposited on the surface of 
the keraƟ nocytes.1,2,3,4 In the paƟ ent's serum, indirect 
immunofl uorescence demonstrates the presence of 
circulating pemphigus autoantibodies that bind to 
epidermis. The Ɵ ter of circulaƟ ng anƟ body correlates 
with disease course.5,6,7
Pathogenesis of pemphigus is the binding of 
autoanƟ bodies to keraƟ nocyte cell surface molecules. 
These intercellular or pemphigus anƟ bodies bind to 
keratinocyte desmosomes and to desmosome-free 
areas of the keraƟ nocyte cell membrane. The binding 
of autoanƟ bodies results in blisters and a loss of cell-cell 
adhesion, a process termed acantholysis.8,9
Pemphigus has the tendency to recurrent and its clinical 
symptoms is varied. Prognosis is worse in patients 
with extensive lesion, especially when associated with 
infecƟ on.10 Therefore, the diagnosis and treatment has 
been one of the issues to focus on to the dermatologists. 
That is why we the choose pemphigus to study its 
features and treatment eff ect.
We analyzed and summarized the clinical manifestaƟ ons 
and the treatment of pemphigus to supply the reference 
of clinical diagnosis and treatment.
MATERIAL AND METHODS 
All paƟ ents diagnosed as pemphigus from the out and 
in-paƟ ent Department of Dermatology and Venereology 
of Lumbini Medical College were selected for the study. 
Their records were reviewed retrospecƟ vely. PaƟ ents 
visiƟ ng from 1st of June 2009 to 31st of May 2013 were 
included in the study. 
Socio-Demographic data and subtype of disease 
were studies. All the data was entered into MicrosoŌ  
Excel and staƟ sƟ cal analyses were performed by the 
SPSS17.0 soŌ ware package and expressed with mean 
and standard deviaƟ on.
RESULTS
There were a total of 70 paƟ ents enrolled in the study. 
Out of those, 38(54%) were male and 32(46%) were 
female. The extent of paƟ ent’s age was from 16 to 82 
years old (mean 41.3 ± 28.5).
Disease was classifi ed into following types:
1. Pemphigus vulgaris
2. Pemphigus vegetans
3. Pemphigus foliaceus
4. Pemphigus erythematosus
5. IgA pemphigus
6. HerpeƟ form  pemphigus
7. ParaneoplasƟ c pemphigus
There were 42  cases of Pemphigus vulgaris accounƟ ng 
for 60% of all those cases. Sixteen cases (22.8%) were 
diagnosed as pemphigus foliaceus. Eight cases (11.4%) 
were of Pemphigus erythematosus variety. There were 
4 cases (5.8%) diagnoses as Pemphigus vegetans. There 
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were no cases of IgA, ParaneoplasƟ c and HerpeƟ form 
pemphigus.
Fig 1: Sex distribuƟ on
THERAPEUTIC EFFECT:
Pemphigus vulgaris: Out of 42 cases, 32 were clinically 
cured and 8 cases were improved. 
Pemphigus foliaceus: All the 16 cases were cured.
Pemphigus erythematosus: All 8 cases were cured.
Pemphigus vegetans: All 4 cases were cured as shown 
in table 2.
Table-1: Types of Pemphigus
Disease Number Percentage
Pemphigus vulgaris 42 60
Pemphigus vegetans 4 5.8
Pemphigus foliaceus 16 22.8
Pemphigus erythematosus 8 11.4
IgA pemphigus 0 0
HerpeƟ form  pemphigus 0 0
ParaneoplasƟ c pemphigus 0 0
Table 2: Results aŌ er treatment
Disease Total Cured Improved
Pemphigus vulgaris 42 34 8
Pemphigus vegetans 4 4 NA
Pemphigus foliaceus 16 16 NA
Pemphigus erythematosus 8 8 NA
IgA pemphigus NA NA NA
HerpeƟ form  pemphigus NA NA NA
ParaneoplasƟ c pemphigus NA NA NA
NA= Not available or Non applicable
DISCUSSION
Pemphigus is a worldwide disease and varies its 
presentaƟ on, clinical profi le, and incidence in diff erent 
regions of the world. In general, the incidence ranges 
from 0.76 to 5 new cases per million per year.11
There was a male dominance in our study with M:F raƟ o 
of 1.18. Overall, the sex raƟ o for pemphigus appears 
to be equivalent or close to equivalent. However, a 
few studies have found large imbalances in the sex 
distribuƟ on, such as a study that found a 4:1 raƟ o of 
females to males with pemphigus foliaceus in Tunisia 
and a study that found a 19:1 raƟ o of males to females 
in an endemic locaƟ on in Columbia.12,13
Pemphigus vulgaris was the most common variety in our 
study. This result was comparable to those reported in 
the majority of the studies.12,13
Treatment was very effective in early and limited 
diseases with 100% cure rate in many cases. Some 
advanced cases were parƟ ally improved. Similar results 
were shown by studies.14,15,16
CONCLUSIONS
Pemphigus is a common dermatological disease. It aff ects 
males more than females. Pemphigus vulgaris is the 
most common clinical type of Pamphigus, accounƟ ng for 
60% of the paƟ ents, followed by pemphigus foliaceus, 
accounƟ ng for 22.8%. IgA pemphigus, ParaneoplasƟ c 
andherpeƟ form pemphigus are rare.
The total cure rate is 88.6%. Treatment is very eff ecƟ ve 
for vegetans, foliaceus and erythematosus types. 
Whereas it is eff ecƟ ve for Pemphigus vulgaris with 
cure rate of 81%. The eff ect of treatment in paƟ ents 
with mild to moderate condiƟ on of pemphigus vulgaris, 
pemphigus foliaceus, pemphigus erythematosus and 
pemphigus vegetans was best, while in serious condiƟ on 
of pemphigus vulgaris it was parƟ al. 
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